Cardiovascular Systems expands manufacturing operations into Texas

Cardiovascular Systems, a developer of interventional treatment systems for vascular disease, has signed a 10-year lease agreement for a new 46,000-square-foot manufacturing facility in Pearland, Texas.

The facility is being built for the St. Paul, Minn.-based Cardiovascular Systems and will support the production of its Diamondback 360° PAD system, a minimally invasive catheter for treating peripheral arterial disease (PAD), and other products.

The company said it could hire approximately 250 employees over the course of five years to work at the Texas facility and manufacture the Diamondback 360°, in addition to continuing its manufacturing operations in Minnesota.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."